How the U.S. Shelved Tariffs on Generic Drugs — A Lifeline for India’s Pharma

White House shelves tariffs on generic drugs, easing pressure on U.S. patients and Indian pharma exports—insight into impact, risks, and strategy. Imagine walking into a pharmacy tomorrow, only to find your essential medications have suddenly skyrocketed in price. For millions of Americans and healthcare systems worldwide, the threat of tariffs on pharmaceutical imports is more … Read more

“Trump’s 100% Pharma Tariff: What It Means for Indian Pharma Drugmakers”

Explore the implications of President Trump’s 100% tariff on branded drugs for Indian pharmaceutical companies like Sun Pharma, Cipla, and Dr. Reddy’s. In a bold move that has sent ripples through the global pharmaceutical industry, President Donald Trump announced a 100% tariff on imported branded and patented drugs, effective October 1, 2025. This decision has … Read more